Latin America Neurovascular Devices Market Size & Outlook

The neurovascular devices market in Latin America is expected to reach a projected revenue of US$ 714.3 million by 2030. A compound annual growth rate of 5.3% is expected of Latin America neurovascular devices market from 2024 to 2030.
Revenue, 2023 (US$M)
$499.1
Forecast, 2030 (US$M)
$714.3
CAGR, 2024 - 2030
5.3%
Report Coverage
Latin America

Latin America neurovascular devices market highlights

  • The Latin America neurovascular devices market generated a revenue of USD 499.1 million in 2023.
  • The market is expected to grow at a CAGR of 5.3% from 2024 to 2030.
  • In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device in 2023.
  • Neurothrombectomy Devices is the most lucrative device segment registering the fastest growth during the forecast period.
  • Country-wise, Argentina is expected to register the highest CAGR from 2024 to 2030.


Latin America data book summary

Market revenue in 2023USD 499.1 million
Market revenue in 2030USD 714.3 million
Growth rate5.3% (CAGR from 2023 to 2030)
Largest segmentCerebral embolization and aneurysm coiling devices
Fastest growing segmentNeurothrombectomy Devices
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCerebral Embolization and aneurysm Coiling devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices
Key market players worldwideMedtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp


Other key industry trends

  • In terms of revenue, Latin America region accounted for 16.6% of the global neurovascular devices market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,092.8 million by 2030.

Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 35.22% in 2023. Horizon Databook has segmented the Latin America neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2018 to 2030.


The neurovascular devices market in Latin America is anticipated to witness a moderate growth rate over the forecast period. Increasing awareness about treatment of acute ischemic stroke and growing healthcare expenditure in Latin America are primary factors expected to drive the market over the forecast period.

In addition, increasing healthcare expenditure in Brazil and gradual adoption of advanced healthcare facilities may positively impact the market growth. 

However, lack of adequate skilled professionals & knowledge regarding proper treatment of acute ischemic stroke in countries such as Mexico, Colombia, and Argentina is likely to impede the market growth in Latin America.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Neurovascular Devices Market Companies

Name Profile # Employees HQ Website

Latin America neurovascular devices market size, by country, 2018-2030 (US$M)

Latin America Neurovascular Devices Market Outlook Share, 2023 & 2030 (US$M)

Latin America neurovascular devices market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more